Organovo

ONVO NASDAQ
0.4531
-0.0069
-1.50%
After Hours: 0.4531 0 0.00% 16:18 07/23 EDT
Open
0.4600
Prev Close
0.4600
High
0.4699
Low
0.4529
Volume
317.21K
Avg Vol (3M)
2.44M
52 Week High
1.380
52 Week Low
0.3701
% Turnover
0.24%
Market Cap
59.01M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Organovo ONVO stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.
MORE >

Recently

Name
Price
%Change